| Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029 C Marquina, S Talic, S Vargas-Torres, M Petrova, D Abushanab, A Owen, ... European Journal of Preventive Cardiology 29 (8), 1212-1219, 2022 | 27 | 2022 |
| Caffeine for the treatment of apnea in the neonatal intensive care unit: a systematic overview of meta-analyses E Alhersh, D Abushanab, S Al-Shaibi, D Al-Badriyeh Pediatric Drugs 22, 399-408, 2020 | 23 | 2020 |
| First-line treatment with empagliflozin and metformin combination versus standard care for patients with type 2 diabetes mellitus and cardiovascular disease in Qatar. A cost … D Abushanab, D Al-Badriyeh, D Liew, Z Ademi Current Problems in Cardiology 47 (6), 100852, 2022 | 17 | 2022 |
| Efficacy and Safety of Ibuprofen Plus Paracetamol in a Fixed-Dose Combination for Acute Postoperative Pain in Adults: Meta-Analysis and a Trial Sequential Analysis DAB Dina Abushanab CNS drugs, 2021 | 13 | 2021 |
| Prophylactic sildenafil in preterm infants at risk of bronchopulmonary dysplasia: a pilot randomized, double-blinded, placebo-controlled trial FF Abounahia, R Abu-Jarir, MF Abounahia, D Al-Badriyeh, D Abushanab, ... Clinical Drug Investigation 39, 1093-1107, 2019 | 13 | 2019 |
| Attainment of low-density lipoprotein cholesterol goals in statin treated patients: Real-world evidence from Australia S Talic, C Marquina, E Zomer, R Ofori-Asenso, M Petrova, ... Current Problems in Cardiology 47 (7), 101068, 2022 | 12 | 2022 |
| Assessment of dasatinib versus nilotinib as upfront therapy for chronic phase of chronic myeloid leukemia in qatar: a cost-effectiveness analysis A Adel, D Abushanab, A Hamad, M Abdulla, M Izham, M Yassin Cancer Control 28, 10732748211001796, 2021 | 11 | 2021 |
| Clinical and economic analysis of morphine versus fentanyl in managing ventilated neonates with respiratory distress syndrome in the intensive care setting D Abushanab, O Alsoukhni, F AbouNahia, D Al-Badriyeh Clinical therapeutics 41 (4), 714-727. e8, 2019 | 11 | 2019 |
| Cost-effectiveness of Oral Versus Intravenous Ibuprofen Therapy in Preterm Infants With Patent Ductus Arteriosus in the Neonatal Intensive Care Setting: A Cohort-based Study PD Dina Abushanab, MPharm Pallivalappila Abdul Rouf, PhD Moza Al Hail ... Clinical Therapeutics, 2021 | 9 | 2021 |
| Use of ibuprofen for the closure of patent ductus arteriosus in preterm infants: a systematic review of meta-analyses S Al-Shaibi, D Abushanab, E Alhersh, R Kaddoura, AR Pallivalappila, ... Journal of Comparative Effectiveness Research 10 (7), 549-568, 2021 | 8 | 2021 |
| Surfactant therapy for meconium aspiration syndrome in neonates: a systematic overview of systematic reviews and recent clinical trials MA Abdelaal, D Abushanab, D Al-Badriyeh Journal of Comparative Effectiveness Research 9 (8), 527-536, 2020 | 8 | 2020 |
| Cost-effectiveness analysis of out-of-hospital versus in-hospital extracorporeal cardiopulmonary resuscitation for out-hospital refractory cardiac arrest D Al-Badriyeh, AA Hssain, D Abushanab Current Problems in Cardiology 47 (12), 101387, 2022 | 7 | 2022 |
| Long-term cost-effectiveness of implementing a lifestyle intervention during pregnancy to reduce the incidence of gestational diabetes and type 2 diabetes M Lloyd, J Morton, H Teede, C Marquina, D Abushanab, DJ Magliano, ... Diabetologia 66 (7), 1223-1234, 2023 | 6 | 2023 |
| A systematic review of cost-effectiveness of non-statin lipid-lowering drugs for primary and secondary prevention of cardiovascular disease in patients with type 2 diabetes … D Abushanab, D Al-Badriyeh, C Marquina, C Bailey, M Jaam, D Liew, ... Current Problems in Cardiology, 101211, 2022 | 6 | 2022 |
| Projected new-onset cardiovascular disease by socioeconomic group in Australia K Hastings, C Marquina, J Morton, D Abushanab, D Berkovic, S Talic, ... Pharmacoeconomics, 1-12, 2022 | 6 | 2022 |
| Cost-effectiveness of empagliflozin and metformin combination versus standard care as first-line therapy in patients with type 2 diabetes mellitus D Abushanab, D Liew, C Marquina, D Al-Badriyeh, Z Ademi Endocrine Practice 28 (1), 16-24, 2022 | 6 | 2022 |
| L-glutamine and crizanlizumab for adults with sickle cell disease (SCD) in qatar: a cost effectiveness analysis AA Adel, D Abushanab, A Hamad, D Al-Badriyeh, MA Yassin Blood 138, 4945, 2021 | 6 | 2021 |
| Clinical and economic evaluation of the impact of midazolam on morphine therapy for pain relief in critically Ill ventilated infants with respiratory distress syndrome D Abushanab, FF Abounahia, O Alsoukhni, M Abdelaal, D Al-Badriyeh Pediatric Drugs 23, 143-157, 2021 | 6 | 2021 |
| Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital D Abushanab, A Gulied, A Hamad, M Abu-Tineh, PV Abdul Rouf, ... Journal of Oncology Pharmacy Practice 29 (8), 1935-1943, 2023 | 4 | 2023 |
| Cost-effectiveness analysis of ibuprofen versus indomethacin or paracetamol for the treatment of patent ductus arteriosus in preterm neonates S Al-Shaibi, D Abushanab, F Abounahia, A Awaisu, D Al-Badriyeh Current Problems in Cardiology 48 (9), 101751, 2023 | 4 | 2023 |
Zanfina AdemiProfessor, Monash UniversityVerified email at monash.edu
